Skip to main content
Tech.euFundingExplorerBeta

Aravis Ventures

Investor profile

Aravis Ventures has backed 3 European tech companies across 4 funding rounds between 2006 and 2024, joining rounds totalling €97M. Most active in Healthtech and Agritech. Data as of 4 Nov 2026.

Deals
4
distinct rounds
Companies
3
backed
Active span
2006–2024
19 yrs
Total round €
€97M
sum of rounds joined

Deals by year

distinct rounds / year
Aravis Ventures — deals by year — interactive chart.
Data table
Aravis Ventures — deals by year
20061
20092
20241

Top sectors

by deals
Aravis Ventures — top sectors — interactive chart.
Data table
Aravis Ventures — top sectors
Healthtech2
Agritech1

Stages

by deals
Aravis Ventures — stages — interactive chart.
Data table
Aravis Ventures — stages
Series B2
Other1
Series C1

Countries

by deals
Aravis Ventures — countries — interactive chart.
Data table
Aravis Ventures — countries
Switzerland3
Belgium1

Co-investment network

shared rounds
Co-investment network — interactive chart.
Aravis Ventures — 4 dealsAravis VenturesLODH Immunology Fund — 2 shared deals · click to openLODH Immunology FundNovartis Venture Fund — 2 shared deals · click to openNovartis Venture FundPictet — 2 shared deals · click to openPictetBZ Bank — 1 shared deals · click to openBZ BankGesval — 1 shared deals · click to openGesvalK&E — 1 shared deals · click to openK&ENoshaq — 1 shared deals · click to openNoshaqSwisscom Ventures — 1 shared deals · click to openSwisscom VenturesVaruma — 1 shared deals · click to openVarumaVinci Capital — 1 shared deals · click to openVinci CapitalWellington Partners — 1 shared deals · click to openWellington Partners

Hover a node for shared-deal counts; click a co-investor to open its profile.

Best viewed on a larger screen.

Portfolio

top 30 by total round €
CompanyCountryRoundsTotal €
NovImmuneSwitzerland2€77M
EvolvaSwitzerland1€18M
Hedera-22Belgium1€2.0M

Biggest deals

top 10 by amount
CompanyStageAmountDate
NovImmuneSeries C€41M2009-05
NovImmuneSeries B€36M2006-06
EvolvaSeries B€18M2009-12
Hedera-22Other€2.0M2024-08
← Back to investors